AIM ImmunoTech Inc

AIM ImmunoTech Inc (AIM) Price Prediction & Forecast

$0.258

+0.009 (+3.36%)At close

Price Predictions

1-Day Price Prediction
+1.03%
1-Week Prediction
+3.09%
1-Month Prediction
2026 Prediction
2030 Prediction

Open in app to unlock longer-horizon forecasts.

Loading chart…

AIM Prediction & Forecast by Similar Chart Analysis

Alphio's AIM stock price prediction model matches the current AIM ImmunoTech Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.26 (+1.03%). The 1-week path is $0.27 (+3.09%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy AIM ImmunoTech Inc Stock?

AIM ImmunoTech Inc is currently trading at $0.26, which is significantly lower than its 52-week high. The RSI is at 58.91, indicating a neutral momentum. However, the stock has a forward P/E of 2.01, suggesting potential undervaluation. The major risk is the substantial year-to-date decline of 78.26%, indicating ongoing challenges.

AIM stock price ended at $0.26 on Friday, after rising +3.36%

AIM ImmunoTech Inc (AIM) last closed at $0.2584, gaining +3.36%. These facts feed the 1-day and 1-week AIM price prediction above.

Forecast Drivers

AIM ImmunoTech Inc (AIM) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

Similar Chart Patterns

Stocks whose recent price path most closely matches AIM, ranked by similarity.

Seasonality analysis for AIM

Historically the probability of a positive August return for AIM is 33.33%. September offers the highest probability of a positive month at 51.22%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started